共 50 条
- [41] Biochemical failure in prostate cancer: Managing patients with limited data - The Moul/Banez/Freedland article reviewed ONCOLOGY-NEW YORK, 2007, 21 (12): : 1449 - +
- [42] QOL and outcomes research in prostate cancer patients with low socioeconomic status - The Kim et al article reviewed ONCOLOGY-NEW YORK, 1999, 13 (06): : 835 - 836
- [43] Lymph Node-Positive Prostate Cancer: The Benefit of Local Therapy THE MITIN ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2013, 27 (07): : 655 - +
- [44] Prostate cancer, PSA, and questions that can only be answered by clinical trials - The Moul/Banez/Freedland article reviewed ONCOLOGY-NEW YORK, 2007, 21 (12): : 1452 - +
- [45] Emerging role of HIFU as a noninvasive ablative method to treat localized prostate cancer - The Barqawi/Crawford article reviewed ONCOLOGY-NEW YORK, 2008, 22 (02): : 137 - +
- [46] The role of cytotoxic chemotherapy in prostate cancer - A critical reevaluation 20 years later - The Eisenberger/Sinibaldi article reviewed ONCOLOGY-NEW YORK, 2006, 20 (08): : 863 - 863
- [47] LHRH Antagonists vs LHRH Agonists: Which Is More Beneficial in Prostate Cancer Therapy? the KEIZMAN article reviewed ONCOLOGY-NEW YORK, 2009, 23 (07): : 631 - 632
- [48] Targeted focal therapy: A minimally invasive ablation technique for early prostate cancer - The Crawford/Barqawi article reviewed ONCOLOGY-NEW YORK, 2007, 21 (01): : 33 - 33
- [49] Prostate Cancer Immunotherapy: the Role for Sipuleucel-T and Other Immunologic Approaches THE GARCIA AND DREICER ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2011, 25 (03): : 261 - 262
- [50] Brachytherapy or Surgery? A Composite View Further Perspectives on Treating Localized Prostate Cancer The Ciezki/Klein Article Reviewed ONCOLOGY-NEW YORK, 2009, 23 (11): : 964 - 966